SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : KDUS, who knows this company?
KDUS 1.6000.0%Jul 2 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Biersack who wrote (57)1/31/1997 3:01:00 PM
From: Boyce Burge   of 117
 
To Bob and others...I have some SERIOUS doubts about this company... their one trick is a crafty way of using yeast genes to mimic human genes, thus enabling them to identify orphan receptor genes that show up in mass sequencing. Then they can seed a yeast bearing a human receptor with genes that expressing random peptides. A yeast that's making a peptide that activates the receptor will grow fast and take over the culture. Then you have both the receptor an the ligand all in a nice package.

All very well, but does it work? Well, in a collaboration with big pharma (the SAME company that owns about a third of KDUS stock) big pharma says yes it works!! were getting "hits"!!. (Check the news on the NASDAQ site) How convenient. Everyone inside the tent says "its working!!!" And everyone benefits as the share price doubles.

But, Does this elaborate scheme actually produce any useful drugs??? Sorry.... no answers to that question for at least a year. In the meanwhile just keep the faith. Aaaaa, excuse me if I dont buy any right now..... KDUS may be a great trading vehicle, but I dont think KDUS can be looked at as a company with a serious platform....not until there is confirmation from OUTSIDE the loop.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext